Evidence map›Paper›PMID 40178174›Full record

ArticleJournal of chemical information and modeling2025

Application of Deep Learning to Predict the Persistence, Bioaccumulation, and Toxicity of Pharmaceuticals.

Dominga Evangelista, Elliot Nelson, Rachael Skyner, Ben Tehan, Mattia Bernetti, Marinella Roberti, Maria Laura Bolognesi, Giovanni Bottegoni

Abstract read
In one paragraph

Article in Journal of chemical information and modeling, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Discovery of TDP-43 aggregation inhibitorsbioRxiv : the preprint server for biology · 2026
    Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dominga EvangelistaDepartment of Pharmacy and Biotechnology, Alma Mater Studiorum─University of Bologna, Via Belmeloro 6, Bologna 40126, Italy.
Elliot NelsonOMass Therapeutics, Building 4000, Chancellor Court, John Smith Dr, Oxford Business Park, ARC, Oxford OX4 2GX, United Kingdom.ORCID 0000-0002-5460-8076
Rachael SkynerOMass Therapeutics, Building 4000, Chancellor Court, John Smith Dr, Oxford Business Park, ARC, Oxford OX4 2GX, United Kingdom.
Ben TehanOMass Therapeutics, Building 4000, Chancellor Court, John Smith Dr, Oxford Business Park, ARC, Oxford OX4 2GX, United Kingdom.
Mattia BernettiDepartment of Biomolecular Sciences, University of Urbino, Urbino 60129, Italy.ORCID 0000-0002-4373-9310
Marinella RobertiDepartment of Pharmacy and Biotechnology, Alma Mater Studiorum─University of Bologna, Via Belmeloro 6, Bologna 40126, Italy.ORCID 0000-0001-9807-2886
Maria Laura BolognesiDepartment of Pharmacy and Biotechnology, Alma Mater Studiorum─University of Bologna, Via Belmeloro 6, Bologna 40126, Italy.ORCID 0000-0002-1289-5361
Giovanni BottegoniDepartment of Biomolecular Sciences, University of Urbino, Urbino 60129, Italy.ORCID 0000-0003-1251-583X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study investigates the application of a deep learning (DL) model, specifically a message-passing neural network (MPNN) implemented through Chemprop, to predict the persistence, bioaccumulation, and toxicity (PBT) characteristics of compounds, with a focus on pharmaceuticals. We employed a clustering strategy to provide a fair assessment of the model performances. By applying the generated model to a set of pharmaceutically relevant molecules, we aim to highlight potential PBT chemicals and extract PBT-relevant substructures. These substructures can serve as structural flags, alerting drug designers to potential environmental issues from the earliest stages of the drug discovery process. Incorporating these findings into pharmaceutical development workflows is expected to drive significant advancements in creating more environmentally friendly drug candidates while preserving their therapeutic efficacy.

Indexed as

Deep LearningDrug DiscoveryHumansNeural Networks, ComputerPharmaceutical PreparationsPharmaceutical Preparations

Identifiers

PMID40178174
PMCPMC12004513

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.